Eric J. Small, MD, on Prostate Cancer: Results From the SPARTAN Trial

2018 Genitourinary Cancers Symposium
Tweet this page

Eric J. Small, MD, of the University of California, San Francisco, discusses phase III findings on apalutamide vs placebo in patients with nonmetastatic castration-resistant prostate cancer (Abstract 161).

Advertisement

Advertisement



Advertisement